A multi-society Delphi consensus statement on new fatty liver disease nomenclature

AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease

(2023) Mary E. Rinella et al.   HEPATOLOGY

Knowledge of liver fibrosis stage among adults with NAFLD / NASH improves adherence to lifestyle changes

(2022) Patrizia Carrieri et al.   LIVER INTERNATIONAL

Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis

(2021) David Petroff et al.   Lancet Gastroenterology & Hepatology

Diagnosis and management of secondary causes of steatohepatitis

(2021) Roman Liebe et al.   JOURNAL OF HEPATOLOGY

EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update

(2021) Annalisa Berzigotti et al.   JOURNAL OF HEPATOLOGY

The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality

(2021) Tom H Karlsen et al.   LANCET

Expert Panel Review to Compare FDA and EMA Guidance on Drug Development and Endpoints in Nonalcoholic Steatohepatitis

(2021) Rohit Loomba et al.   GASTROENTEROLOGY

Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis

(2020) Rod S. Taylor et al.   GASTROENTEROLOGY

MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease

(2020) Mohammed Eslam et al.   GASTROENTEROLOGY

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

(2020) Mohammed Eslam et al.   JOURNAL OF HEPATOLOGY

From NAFLD to MAFLD: Implications of a premature change in terminology

(2020) Zobair M Younossi et al.   HEPATOLOGY

The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease

(2020) Mohammed Eslam et al.   Hepatology International

The times they are a-changin' (for NAFLD as well)

(2020) Vlad Ratziu et al.   JOURNAL OF HEPATOLOGY

Reply to: correspondence regarding “A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement”

(2020) Mohammed Eslam et al.   JOURNAL OF HEPATOLOGY

“Dual aetiology fatty liver disease”: A recently proposed term associated with potential pitfalls

(2020) Christophe Moreno et al.   JOURNAL OF HEPATOLOGY

Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

(2019) Peter J. Eddowes et al.   GASTROENTEROLOGY

Report on the AASLD/EASL Joint Workshop on Clinical Trial Endpoints in NAFLD

(2019) Mary E. Rinella et al.   HEPATOLOGY

Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science

(2018) Mohammad Shadab Siddiqui et al.   HEPATOLOGY

Developing an acupuncture protocol for treating phantom limb pain: a Delphi consensus study

(2014) Esmé G Trevelyan et al.   Acupuncture in Medicine

Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients

(2012) Pierre Bedossa et al.   HEPATOLOGY

Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography

(2011) Vincent Wai-Sun Wong et al.   GUT

Harmonizing the Metabolic Syndrome

(2009) K.G.M.M. Alberti et al.   CIRCULATION